C12N 2795/10342
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2795/10342 (Virus or viral particle as vehicle) appears on 4 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 11
- Assignees
- 4
- Inventors
- 10
- Latest grant
- 21 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 3 |
By publication year.
Recent patents
- Chimeric receptor binding proteins resistant to proteolytic degradation21 Feb 2023US 11,584,781 B2Eligo Bioscience
- Bacterial delivery vehicles comprising tracer nucleic acid sequences23 Aug 2022US 11,421,222 B2Eligo Bioscience
- Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase7 Jul 2020US 10,702,591 B2Panacea Pharmaceuticals, Inc.
- Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)29 Aug 2017US 9,744,223 B2Panacea Pharmaceuticals, Inc.
- Cancer eradicating - bio-nanoparticles (ce-bnp)2 Nov 2023US 2023/0346862 A1Athanor Biosciences, Inc.
- Chimeric receptor binding proteins resistant to proteolytic degradation4 May 2023US 2023/0134572 A1Eligo Bioscience
- Bacterial delivery vehicles comprising tracer nucleic acid sequences13 Apr 2023US 2023/0112827 A1Eligo Bioscience
- Chimeric receptor binding proteins resistant to proteolytic degradation21 Apr 2022US 2022/0119458 A1Eligo Bioscience
- Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles3 Mar 2022US 2022/0064223 A1Eligo Bioscience
Most cited
By later US patents